InterVene, Inc.

🗓 Founded 2011👥 15 employees💰 Last funded Oct 2019
Medical Equipment Manufacturing🌐 intervene-med.com
Website LinkedIn
InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that. InterVene was originally a product of the Stanford Biodesign Fellowship and is a former Company In Residence at the Fogarty Institute for Innovation. InterVene's offices are now located in South San Francisco near SFO airport.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2011–2019 · investors recorded per year
201112012120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in InterVene, Inc.?
InterVene, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did InterVene, Inc. last raise funding?
The most recent investment in InterVene, Inc. recorded on gritt.io was in October 2019.
When was InterVene, Inc. founded?
InterVene, Inc. was founded in 2011.
What industry is InterVene, Inc. in?
InterVene, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.